Géraldine Farjot

1.5k total citations · 1 hit paper
24 papers, 1.2k citations indexed

About

Géraldine Farjot is a scholar working on Molecular Biology, Developmental Neuroscience and Emergency Medicine. According to data from OpenAlex, Géraldine Farjot has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Developmental Neuroscience and 4 papers in Emergency Medicine. Recurrent topics in Géraldine Farjot's work include Anesthesia and Neurotoxicity Research (6 papers), Cardiac Arrest and Resuscitation (4 papers) and Mitochondrial Function and Pathology (3 papers). Géraldine Farjot is often cited by papers focused on Anesthesia and Neurotoxicity Research (6 papers), Cardiac Arrest and Resuscitation (4 papers) and Mitochondrial Function and Pathology (3 papers). Géraldine Farjot collaborates with scholars based in France, Australia and United States. Géraldine Farjot's co-authors include Klaus Okkenhaug, Andrew J. H. Smith, Michael D. Waterfield, Bart Vanhaesebroeck, Antonio Bilancio, Ashreena Salpekar, Wayne Pearce, Sara Sancho, Emma Peskett and Helen Priddle and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Virology.

In The Last Decade

Géraldine Farjot

21 papers receiving 1.2k citations

Hit Papers

Impaired B and T Cell Antigen Receptor Signaling in p110δ... 2002 2026 2010 2018 2002 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Géraldine Farjot France 12 569 448 258 243 129 24 1.2k
Joseph C. Marini United States 17 376 0.7× 748 1.7× 177 0.7× 97 0.4× 86 0.7× 29 1.5k
Bart A. Westerman Netherlands 21 769 1.4× 110 0.2× 225 0.9× 181 0.7× 63 0.5× 52 1.3k
Manoj Kumar Kashyap United States 23 792 1.4× 161 0.4× 298 1.2× 95 0.4× 58 0.4× 57 1.3k
Zhong Wu China 23 922 1.6× 132 0.3× 328 1.3× 138 0.6× 111 0.9× 86 1.7k
Qiao‐Nan Guo China 20 828 1.5× 124 0.3× 325 1.3× 82 0.3× 116 0.9× 60 1.3k
Peta A. Tilbrook Australia 21 737 1.3× 484 1.1× 402 1.6× 176 0.7× 84 0.7× 31 1.5k
Leigh Samsel United States 26 568 1.0× 612 1.4× 422 1.6× 247 1.0× 207 1.6× 45 1.8k
Petra Leukel Germany 16 559 1.0× 281 0.6× 293 1.1× 274 1.1× 179 1.4× 30 1.5k
Dana A. M. Mustafa Netherlands 20 589 1.0× 401 0.9× 476 1.8× 245 1.0× 88 0.7× 84 1.4k
Béatrice Cambien France 17 479 0.8× 460 1.0× 368 1.4× 67 0.3× 96 0.7× 29 1.6k

Countries citing papers authored by Géraldine Farjot

Since Specialization
Citations

This map shows the geographic impact of Géraldine Farjot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Géraldine Farjot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Géraldine Farjot more than expected).

Fields of papers citing papers by Géraldine Farjot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Géraldine Farjot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Géraldine Farjot. The network helps show where Géraldine Farjot may publish in the future.

Co-authorship network of co-authors of Géraldine Farjot

This figure shows the co-authorship network connecting the top 25 collaborators of Géraldine Farjot. A scholar is included among the top collaborators of Géraldine Farjot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Géraldine Farjot. Géraldine Farjot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rousseaud, Audrey, et al.. (2023). Gaseous nitric oxide failed to inhibit the replication cycle of SARS-CoV-2 in vitro. Nitric Oxide. 132. 27–33. 3 indexed citations
2.
Lemaire, Joël, Essyllt Louarn, Ira Katz, et al.. (2022). Argon pharmacokinetics. Medical Gas Research. 13(4). 208–211.
3.
Roux, Quentin de, Fanny Lidouren, Matthias Kohlhauer, et al.. (2021). Argon Attenuates Multiorgan Failure in Relation with HMGB1 Inhibition. International Journal of Molecular Sciences. 22(6). 3257–3257. 7 indexed citations
4.
5.
Winkler, David A., Ira Katz, Andrew C. Warden, Aaron W. Thornton, & Géraldine Farjot. (2021). Identifying medically relevant xenon protein targets by in silico screening of the structural proteome. Medical Gas Research. 13(1). 33–38. 4 indexed citations
6.
Katz, Ira, et al.. (2019). Numerical analysis of mechanical ventilation using high concentration medical gas mixtures in newborns. Medical Gas Research. 9(4). 213–213. 4 indexed citations
7.
Lavaur, Jérémie, Aude Milet, Ira Katz, et al.. (2019). Neuroprotection of dopamine neurons by xenon against low-level excitotoxic insults is not reproduced by other noble gases. Journal of Neural Transmission. 127(1). 27–34. 12 indexed citations
8.
Winkler, David A., Andrew C. Warden, T. Prangé, et al.. (2019). Massive in Silico Study of Noble Gas Binding to the Structural Proteome. Journal of Chemical Information and Modeling. 59(11). 4844–4854. 8 indexed citations
9.
Baufreton, Jérôme, Tomislav Milekovic, Qin Li, et al.. (2018). Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism. Movement Disorders. 33(10). 1632–1642. 13 indexed citations
10.
Winkler, David A., Ira Katz, Géraldine Farjot, Andrew C. Warden, & Aaron W. Thornton. (2018). Decoding the Rich Biological Properties of Noble Gases: How Well Can We Predict Noble Gas Binding to Diverse Proteins?. ChemMedChem. 13(18). 1931–1938. 9 indexed citations
11.
Katz, Ira, et al.. (2017). A physiologically based model for denitrogenation kinetics. Medical Gas Research. 7(4). 256–256.
12.
Lavaur, Jérémie, Marc Lemaire, Jan Pype, et al.. (2017). The noble gas xenon provides protection and trophic stimulation to midbrain dopamine neurons. Journal of Neurochemistry. 142(1). 14–28. 36 indexed citations
13.
Winkler, David A., Aaron W. Thornton, Géraldine Farjot, & Ira Katz. (2016). The diverse biological properties of the chemically inert noble gases. Pharmacology & Therapeutics. 160. 44–64. 50 indexed citations
14.
Katz, Ira, et al.. (2016). Gas transport during in vitro and in vivo preclinical testing of inert gas therapies. Medical Gas Research. 6(1). 14–14. 4 indexed citations
15.
Hiriart, Edwige, Évelyne Manet, Henri Gruffat, et al.. (2003). A Region of the Epstein-Barr Virus (EBV) mRNA Export Factor EB2 Containing an Arginine-rich Motif Mediates Direct Binding to RNA. Journal of Biological Chemistry. 278(39). 37790–37798. 56 indexed citations
16.
Okkenhaug, Klaus, Antonio Bilancio, Géraldine Farjot, et al.. (2002). Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice. Science. 297(5583). 1031–1034. 761 indexed citations breakdown →
17.
Hiriart, Edwige, Géraldine Farjot, Henri Gruffat, et al.. (2002). A Novel Nuclear Export Signal and a REF Interaction Domain Both Promote mRNA Export by the Epstein-Barr Virus EB2 Protein. Journal of Biological Chemistry. 278(1). 335–342. 73 indexed citations
18.
Farjot, Géraldine, et al.. (2000). Characterization of the Epstein–Barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1. Microbiology. 81(7). 1791–1799. 16 indexed citations
19.
Farjot, Géraldine, Monique Buisson, Madeleine Duc Dodon, et al.. (2000). Epstein-Barr Virus EB2 Protein Exports Unspliced RNA via a Crm-1-Independent Pathway. Journal of Virology. 74(13). 6068–6076. 61 indexed citations
20.
Farjot, Géraldine, Alain Sergeant, & Ivan Mikaélian. (1999). A New Nucleoporin-like Protein Interacts with Both HIV-1 Rev Nuclear Export Signal and CRM-1. Journal of Biological Chemistry. 274(24). 17309–17317. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026